After clearing regulators at home on Wednesday, the partners face the challenge of convincing medicine watchdogs in the U.S. and elsewhere that their missteps are behind them and that their vaccine, ...
Full trial results are expected by Christmas but late-stage human trials have shown it develops antibody and t-cell responses in elderly patients. The latest data, made available on Thursday, revealed ...
The vaccine produced by British-Swedish pharmaceutical firm AstraZeneca and Oxford University, 30 million doses of which will be produced in Australia, appears to be more effective the less of it is ...
Full trial results are expected by Christmas but late-stage human trials have shown it develops antibody and t-cell responses in elderly patients. The latest data, made available on Thursday, revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results